Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05053022 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo
A NA study, sponsored by Crown Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05053022 is a NA study that has completed, run by Crown Laboratories. The registered enrollment target is 13 participants.
The verdict
NCT05053022, a NA study, has completed, sponsored by Crown Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a study that is being conducted in order to assess the efficacy of microneedling as a stand-alone treatment for vitiligo. Vitiligo is an autoimmune depigmentation disease of the skin that is characterized by the destruction of epidermal melanocytes by CD8+ T cells. The pathogenesis of Vitiligo has been linked to autoimmunity, oxidative stress, and genetic susceptibility.
Interventions
- DEVICE Skinpen Precision System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-07-29 |
| Est. Completion | 2023-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05053022
The ClinicalTrials.gov registry entry for NCT05053022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Crown Laboratories, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Skinpen Precision System is the first listed.
NCT05053022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05053022 about?
NCT05053022 is a clinical study titled "A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo". This is a study that is being conducted in order to assess the efficacy of microneedling as a stand-alone treatment for vitiligo. Vitiligo is an autoimmune depigmentation disease of the skin that is characterized by the destruction of epidermal melanocytes by CD8+ T cells. The pathogenesis of Vitili...
What is the current status of trial NCT05053022?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-07-29. Estimated completion is 2023-01-24.
What interventions are being tested in trial NCT05053022?
The interventions under investigation include: Skinpen Precision System (DEVICE).
Who is sponsoring clinical trial NCT05053022?
This trial is sponsored by Crown Laboratories, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.